26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

pituitary hormones 574 plaque-forming cell (PFC) assay<br />

Clemens Peter Freiherr von Pirquet.<br />

and adrenocorticotrophic hormone (ACTH) deficiency.<br />

They may portend an unfavorable consequence of pituitary<br />

microsurgery for Cushing’s disease. Forty-eight percent<br />

of children with cryptorchidism may develop autoantibodies<br />

against follicle-stimulating hormone (FSH)-secreting<br />

and luteinizing hormone (LH)-secreting pituitary cells.<br />

Autoantibodies against pituitary hormones have been discovered<br />

in 45% of patients with pituitary tumors or empty<br />

sella syndrome but not in normal individuals; 100% develop<br />

ACTH autoantibodies, and 20% form thyroid-stimulating<br />

hormone (TSH) and growth hormone (GH) autoantibodies.<br />

Empty sella syndrome may be induced by hypophysitis secondary<br />

to pituitary autoantibodies in adults. Autoantibodies<br />

against prolactin develop in 16% of patients with idiopathic<br />

hyperprolactinemia. Patients with these autoantibodies do<br />

not usually have clinical symptoms of hyperprolactinemia.<br />

pituitary hormones<br />

Immunoperoxidase staining of pituitary adenomas with<br />

antibodies to adrenocorticotrophic hormone (ACTH),<br />

growth hormone (GH), prolactin, follicle-stimulating<br />

hormone (FSH), and luteinizing hormone (LH) facilitates<br />

definition of their clinical phenotype.<br />

P1 kinase<br />

A serine/threonine kinase activated by interferons α and β.<br />

It prevents translation by phosphorylating eIF2, the eukaryotic<br />

protein synthesis initiation factor. This facilitates inhibition<br />

of viral replication.<br />

PK reaction<br />

Refer to Prausnitz–Küstner reaction.<br />

PK test<br />

Abbreviation for Prausnitz–Küstner reaction.<br />

plague vaccine<br />

Yersinia pestis microorganisms killed by heat or formalin<br />

are injected intramuscularly to induce immunity against<br />

plague. It is administered in three doses 4 weeks or more<br />

apart. The duration of the immunity is approximately<br />

6 months. A live attenuated vaccine, used mainly in Java, has<br />

also been found to induce protective immunity. An immunizing<br />

preparation is prepared from a crude fraction of killed<br />

Yersinia pestis plague microorganisms or synthetically from<br />

recombinant proteins. It is rarely used except in a laboratory<br />

or for field workers in regions where plague is endemic.<br />

plantibodies<br />

Antibodies derived from plants such as tobacco that may be<br />

used in research. They may prove less immunogenic than<br />

murine antibodies. Antibody-like substances synthesized by<br />

transgenic plants.<br />

Plant immunity.<br />

plant immunity<br />

Immunity in higher plants consists of an immune state of<br />

systemic acquired resistance (SAR) that follows a local<br />

infection by pathogenic microorganisms that leads to<br />

lesions with death of host cells. SAR encompasses a broad<br />

spectrum of bacterial, viral, and fungal agents, as well as<br />

the infective pathogen. Various SAR genes encode numerous<br />

microbicidal proteins induced by endogenous chemicals<br />

that include salicylic acid, which combines with a catalase<br />

to increase H 2O 2, which may facilitate defense.<br />

Top view of<br />

petri dish<br />

Hemolytic plaque<br />

Plaque-forming cell (PFC) assay.<br />

Plaque-<br />

forming<br />

cell<br />

plaque-forming assay<br />

Refer to hemolytic plaque assay.<br />

plaque-forming cell (PFC) assay<br />

Technique for demonstrating and enumerating cells forming<br />

antibodies against a specific antigen. Mice are immunized<br />

with sheep red blood cells (SRBCs). After a specified period,<br />

a suspension of splenic cells from the immunized mouse<br />

is mixed with antigen (SRBC) and spread on a suitable<br />

semisolid gel medium. After or during incubation at 37°C,<br />

complement is added. The erythrocytes that have anti-SRBC

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!